6-Mercaptopurine-13C2 15N

6-Mercaptopurine is a medication used for treating leukemia and other cancers. The 6-Mercaptopurine-13C2 15N is a stable isotope-labeled variant of the drug. This isotope-labeled form is used in research and clinical settings to study the drug's pharmacokinetics and metabolism. The chemical structure of 6-Mercaptopurine-13C2 15N contains two isotopes, 13C and 15N, which can be detected and tracked using analytical techniques like mass spectrometry. This allows researchers to measure the bioavailability and distribution of the drug in the body, as well as its breakdown products and interactions with other drugs. Additionally, the use of stable isotopes in drug research and development allows for precise and accurate quantification of drug concentrations in clinical samples, which is critical for determining optimal dosing and minimizing toxic side effects. In summary, the use of 6-Mercaptopurine-13C2 15N is crucial for studying the pharmacokinetics and metabolism of 6-Mercaptopurine, which ultimately helps improve the safety and efficacy of the drug in clinical settings.